Corrigendum to "Almonertinib inhibits liver cancer progression by triggering autophagy-dependent ferroptosis through inhibition of the PI3K/Akt1/mTOR pathway". [Biochem. Pharmacol. 245 (2026) 117628]. — SciRadar